This page features scientific coverage from ACC.18 – including summary slides of the hottest late-breaking clinical trials, video interviews with experts, trial summaries, journal scans and more. This post-meeting content is meant to reinforce the teaching points and education presented during ACC.18 from three learning pathways: Heart Failure and Cardiomyopathies, Interventional Cardiology and Prevention. Click on each pathway name to see the content. Stay tuned as additional content will be added in the coming months.

Prevention


Drs. Kim Eagle, Tina Shah and Salim Virani review canagliflozin for heart failure prevention in type 2 Diabetes (CANVAS); and canakinumab among patients with chronic kidney disease (CANTOS).

iScience Video: Top Three Presentations in Dyslipidemia Most Likely to Impact or Change Clinical Practice or Future Research Agendas
Presenter: Michael Shapiro
Session: 1403-06
Clinical Trial: ACCELERATE Clinical Trial Summary

Drs. Peter Block, Bina Ahmed and Deepak Bhatt review the cost effectiveness of instantaneous wave-free ratio vs. FFR in coronary revascularization decision-making (DEFINE-FLAIR); CYP2C19 genotyping implementation after PCI (ADAPT); and five-Year outcomes from the all-comers Nordic Aortic Valve Intervention in patients with severe AV stenosis (NOTION).

Summary Slide: SMART DATE: Safety of 6-Month Duration of DAPT After PCI in ACS
Clinical Trial: SMART DATE: Safety of 6-Month Duration of DAPT After PCI in ACS
iScience Video: Defining the Population: Who Is the CHIP Patient?
Presenter: Habib Samady
Session: 631
Summary Slide: ODYSSEY OUTCOMES: Evaluation of CV Outcomes After ACS During Treatment With Alirocumab
Clinical Trial: ODYSSEY OUTCOMES: Evaluation of CV Outcomes After ACS During Treatment With Alirocumab

Drs. Kim Eagle, Monica Colvin and Ragavendra Baliga review MagLev Technology in patients undergoing mechanical circulatory support therapy with HeartMate 3 (MOMENTUM 3); and carvedilol for prevention of chemotherapy-Induced Cardiotoxicity (CECCY).

Summary Slide: MOMENTUM-3: MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3
Summary Slide: CECCY: Carvedilol Effect in Preventing Chemotherapy Induced Cardiotoxicity
iScience Video: LVAD 101-201: Moving From Basic to Advanced Concepts
Presenter: Francis Pagani
Session: 611


News From ACC 2018

View All ACC.18 News Coverage >>>